29 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
7 Dec 20
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
9:17am
and in-vitro diagnostics. He has served in a variety of senior business and operational leadership roles, including 15 years at the executive committee level … board-level positions in joint ventures in Japan and China.
Earlier in his career, Mr. Harbin held multiple leadership roles within Eli Lilly
8-K
EX-99.1
ONCR
Oncorus, Inc.
15 Jun 21
Regulation FD Disclosure
7:15am
encoding for oncolytic viruses encapsulated within lipid nanoparticles (LNPs)
Oncorus’ leadership will discuss its Synthetic vRNA Platform and lead … -administered viral immunotherapies to address significant unmet needs.
Oncorus leadership will discuss the company’s pioneering IV-administered approach
8-K
EX-99.1
ONCR
Oncorus, Inc.
4 Jan 21
Entry into a Material Definitive Agreement
4:12pm
function. Previously, he held senior executive manufacturing and operations leadership roles in the U.S. and globally with Moderna, Inc., bioMérieux SA … ; the ability of the leadership team to execute Oncorus’ strategy and support its future growth; and statements regarding the accomplishments, experience
8-K
EX-99.1
ONCR
Oncorus, Inc.
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am
of directors.
“We are thrilled to welcome Doug to our board and leverage his significant expertise and executive leadership skills as we work to advance our … with my fellow board members and Oncorus’ leadership team to advance this potentially paradigm-shifting approach to cancer treatment.”
Dr. Fambrough brings
8-K
EX-99.1
ONCR
Oncorus, Inc.
21 Jun 21
Oncorus Appoints Eric Rubin, M.D. to its Board of Directors
4:03pm
and industry career in cancer drug development, including his oncology leadership roles at Merck, known as MSD outside of the United States and Canada … to lead the clinical oncology development team. Under his leadership, the clinical oncology group underwent a transformational change to realize
8-K
EX-99.1
bfczfgg
14 Dec 20
Oncorus Appoints Scott Canute to its Board of Directors
9:03am
8-K
EX-99.1
wug69 4f3n
9 Mar 22
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:46am
8-K
EX-99.1
tal61l7zpe8
10 Mar 21
Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
7:15am
8-K
EX-99.1
w74bzbil02
29 Jul 21
Oncorus Expands its Board with Appointment of Barbara Yanni
4:31pm
8-K
jt5ud8lwb19 bcq5rik
7 Dec 20
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
9:17am
10-K/A
vvbc461lrltitx7
29 Apr 22
Annual report (amended)
4:06pm
8-K
EX-99.1
yzs5suo
4 Aug 21
Oncorus Reports Second Quarter 2021 Financial Results and Provides Business Highlights
7:09am
DEF 14A
m6n57
28 Apr 21
Definitive proxy
4:06pm
8-K
EX-99.1
1s6q8t5zj24s2
10 Jan 22
Regulation FD Disclosure
8:17am
424B4
qk4pk58ybtrh8
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
2x6o7t6rkc
28 Jan 21
Draft registration statement
12:00am